|
1
|
Kochanek KD, Murphy SL, Xu J and
Tejada-Vera B: Deaths: Final data for 2014. Natl Vital Stat Rep.
65:1–122. 2016.PubMed/NCBI
|
|
2
|
Zoghbi HY and Orr HT: Pathogenic
mechanisms of a polyglutamine-mediated neurodegenerative disease,
spinocerebellar ataxia type 1. J Biol Chem. 284:7425–7429. 2009.
View Article : Google Scholar :
|
|
3
|
Tsuji S: Genetics of neurodegenerative
diseases: Insights from high-throughput resequencing. Hum Mol
Genet. 19:R65–R70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen WW, Zhang X and Huang WJ: Role of
neuroinflammation in neurodegenerative diseases (Review). Mol Med
Rep. 13:3391–3396. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Uttara B, Singh AV, Zamboni P and Mahajan
RT: Oxidative stress and neurodegenerative diseases: A review of
upstream and downstream antioxidant therapeutic options. Curr
Neuropharmacol. 7:65–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soto C and Estrada LD: Protein misfolding
and neurodegeneration. Arch Neurol. 65:184–189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cherry JD, Olschowka JA and O'Banion MK:
Neuroinflammation and M2 microglia: the good, the bad, and the
inflamed. J Neuroinflammation. 11:982014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao L, Kan EM, Lu J, Hao A, Dheen ST, Kaur
C and Ling EA: Toll-like receptor 4 mediates microglial activation
and production of inflammatory mediators in neonatal rat brain
following hypoxia: Role of TLR4 in hypoxic microglia. J
Neuroinflammation. 10:232013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Banks WA, Gray AM, Erickson MA, Salameh
TS, Damodarasamy M, Sheibani N, Meabon JS, Wing EE, Morofuji Y,
Cook DG and Reed MJ: Lipopolysaccharide-induced blood-brain barrier
disruption: Roles of cyclooxygenase, oxidative stress,
neuroinflammation, and elements of the neurovascular unit. J
Neuroinflammation. 12:2232015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morgan MJ and Liu ZG: Crosstalk of
reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115.
2011. View Article : Google Scholar
|
|
11
|
Hutchins AP, Diez D and Miranda-Saavedra
D: The IL-10/STAT3-mediated anti-inflammatory response: Recent
developments and future challenges. Brief Funct Genomics.
12:489–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hashim P: Centella asiatica in food and
beverage applications and its potential antioxidant and
neuroprotective effect. Int Food Res J. 18:1215–1222. 2011.
|
|
13
|
Su Z, Ye J, Qin Z and Ding X: Protective
effects of madecassoside against doxorubicin induced nephrotoxicity
in vivo and in vitro. Sci Rep. 5:183142015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nurlaily A, Noor BA and Musalmah M:
Comparative antioxidant and anti-inflammatory activity of different
extracts of Centella asiatica (L.) Urban and its active compounds,
asiaticoside and madecassoside. Med Health. 7:62–72. 2012.
|
|
15
|
Li SQ, Xie YS, Meng QW, Zhang J and Zhang
T: Neuroprotective properties of Madecassoside from Centella
asiatica after hypoxic-ischemic injury. Pak J Pharm Sci.
29:2047–2051. 2016.
|
|
16
|
Kumar H, More SV, Han SD, Choi JY and Choi
DK: Promising therapeutics with natural bioactive compounds for
improving learning and memory-a review of randomized trials.
Molecules. 17:10503–10539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mohan JRJ: Investigating
anti-neuroinflammatory responses in lipopolysaccharide-stimulated
BV2 microglia cells upon treatment with madecassoside
(Dissertation). Kuala Lumpur (MY): International Medical
University; 2016
|
|
18
|
Ajmone-Cat MA, Bernardo A, Greco A and
Minghetti L: Non-steroidal anti-inflammatory drugs and brain
inflammation: Effects on microglial functions. Pharmaceuticals.
3:1949–1964. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol Appendix. 3:Appendix3B2001.
|
|
20
|
Park E, Kim DK and Chun HS: Resveratrol
inhibits lipopolysaccharide-induced phagocytotic activity in BV2
cells. J Korean Soc App Biolo Chemistry. 55:803–807. 2012.
View Article : Google Scholar
|
|
21
|
Zhang T, Gong X, Hu G and Wang X: EP2-PKA
signaling is suppressed by triptolide in lipopolysaccharide-induced
microglia activation. J Neuroinflammation. 12:502015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Popa-Wagner A, Mitran S, Sivanesan S,
Chang E and Buga AM: ROS and brain diseases: The good, the bad, and
the ugly. Oxid Med Cell Longev. 2013:9635202013. View Article : Google Scholar
|
|
24
|
Phanjedra A, Jestadi DB and Periyasamy L:
Free radicals: Properties, sources, targets, and their implication
in various diseases. Indian J Clin Biochem. 30:11–26. 2015.
View Article : Google Scholar
|
|
25
|
Ma MW, Wang J, Zhang Q, Wang R, Dhandapani
KM, Vadlamudi RK and Brann DW: NADPH oxidase in brain injury and
neurodegenerative disorders. Mol Neurodegener. 12:72017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Al Mamun A, Hashimoto M, Katakura M,
Matsuzaki K, Hossain S, Arai H and Shido O: Neuroprotective effect
of madecassoside evaluated using amyloid B1-42-mediated in vitro
and in vivo Alzheimer's Disease models. Int J Indigenous Med
Plants. 47:2051–4263. 2014.
|
|
27
|
Aoshiba K, Yasuda K, Yasui S, Tamaoki J
and Nagai A: Serine proteases increase oxidative stress in lung
cells. Am J Physiol Lung Cell Mol Physiol. 281:L556–L564. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo Y, Yang YP, Liu J, Li WH, Yang J, Sui
X, Yuan X, Nie ZY, Liu YQ, Chen D, et al: Neuroprotective effects
of madecassoside against focal cerebral ischemia reperfusion injury
in rats. Brain Res. 1565:37–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hörl WH: Nonsteroidal anti-inflammatory
drugs and the kidney. Pharmaceuticals. 3:2291–2321. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maity P, Bindu S, Dey S, Goyal M, Alam A,
Pal C, Mitra K and Bandyopadhyay U: Indomethacin, a non-steroidal
anti-inflammatory drug, develops gastropathy by inducing reactive
oxygen species-mediated mitochondrial pathology and associated
apoptosis in gastric mucosa. J Biol Chem. 284:3058–3068. 2009.
View Article : Google Scholar
|
|
31
|
Wang X, Zhao Q, Matta R, Meng X, Liu X,
Liu CG, Nelin LD and Liu Y: Inducible Nitric-oxide synthase
expression is regulated by mitogen-activated protein kinase
phosphatase-1. J Biol Chem. 284:27123–27134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Garry PS, Ezra M, Rowland MJ, Westbrook J
and Pattinson KT: The role of the nitric oxide pathway in brain
injury and its treatment-From bench to bedside. Exp Neurol.
263:235–243. 2015. View Article : Google Scholar
|
|
33
|
Nascimento FR, Gomes EA, Russo M and
Lepique AP: Interferon regulatory factor (IRF)-1 is a master
regulator of the cross talk between macrophages and L929
fibrosarcoma cells for nitric oxide dependent tumoricidal activity.
PLoS One. 10:e01177822015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Olivera GC, Ren X, Vodnala SK, Lu J, Coppo
L, Leepiyasakulchai C, Holmgren A, Kristensson K and Rottenberg ME:
Nitric oxide protects against infection-induced neuroinflammation
by preserving the stability of the blood brain barrier. PLoS
Pathog. 12:e10054422016. View Article : Google Scholar
|
|
35
|
An HJ, Kim IT, Park HJ, Kim HM, Choi JH
and Lee KT: Tormentic acid, a triterpenoid saponin, isolated from
Rosa rugosa, inhibited LPS-induced iNOS, COX-2, and TNF-α
expression through inactivation of the nuclear factor-κb pathway in
RAW 264.7 macrophages. Int Immunopharmacol. 11:504–510. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Won JH, Shin JS, Park HJ, Jung HJ, Koh DJ,
Jo BG, Lee JY, Yun K and Lee KT: Anti-inflammatory effects of
madecassic acid via the suppression of NF-kappaB pathway in
LPS-induced RAW 264.7 macrophage cells. Planta Med. 76:251–257.
2010. View Article : Google Scholar
|
|
37
|
Ricciotti E and FitzGerald GA:
Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol.
31:986–1000. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang G, Sarkar P, Peterson JR, Anrather J,
Pierce JP, Moore JM, Feng J, Zhou P, Milner TA, Pickel VM, et al:
COX-1-derived PGE2 and PGE2 type 1 receptors
are vital for angiotensin II-induced formation of reactive oxygen
species and Ca2+ influx in the subfornical organ. Am J
Physiol Heart Circ Physiol. 305:H1451–H1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanna N, Bonifacio L, Reddy P, Hanna I,
Weinberger B, Murphy S, Laskin D and Sharma S: IFN-gamma-mediated
inhibition of COX-2 expression in the placenta from term and
preterm labor pregnancies. Am J Reprod Immunol. 51:311–318. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Klampfer L, Huang J, Kaler P, Sasazuki T,
Shirasawa S and Augenlicht L: STAT1-independent inhibition of
cyclo-oxygenase-2 expression by IFNgamma; a common pathway of
IFNgamma-mediated gene repression but not gene activation.
Oncogene. 26:2071–2081. 2007. View Article : Google Scholar
|
|
41
|
Turnquist C, Wang Y, Severson DT, Zhong S,
Sun B, Ma J, Constaninescu SN, Ansorge O, Stolp HB, Molnár Z, et
al: STAT1-induced ASPP2 transcription identifies a link between
neuroinflammation, cell polarity, and tumor suppression. Proc Natl
Acad Sci USA. 111:9834–9839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Stockinger S and Decker T: Novel functions
of type I interferons revealed by infection studies with Listeria
monocytogenes. Immunobiology. 213:889–897. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang C, Li B, Gaikwad AS, Haridas V, Xu
Z, Gutterman JU and Duvic M: Avicin D selectively induces apoptosis
and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell
lymphoma cells. J Invest Dermatol. 128:2728–2735. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pandey MK, Sung B and Aggarwal BB:
Betulinic acid suppresses STAT3 activation pathway through
induction of protein tyrosine phosphatase SHP-1 in human multiple
myeloma cells. Int J Cancer. 127:282–292. 2010.
|
|
45
|
Lawrence T: The nuclear factor NF-κappaB
pathway in inflammation. Cold Spring Harb Perspect Biol.
1:a0016512009. View Article : Google Scholar
|
|
46
|
Jatana M, Giri S, Ansari MA, Elango C,
Singh AK, Singh I and Khan M: Inhibition of NF-kappaB activation by
5-lipoxygenase inhibitors protects brain against injury in a rat
model of focal cerebral ischemia. J Neuroinflammation. 3:122006.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yamamoto Y and Gaynor RB: Therapeutic
potential of inhibition of the NF-kappaB pathway in the treatment
of inflammation and cancer. J Clin Invest. 107:135–142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yin MJ, Yamamoto Y and Gaynor RB: The
anti-inflammatory agents aspirin and salicylate inhibit the
activity of I(kappa)B kinase-beta. Nature. 396:77–80. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pierce JW, Read MA, Ding H, Luscinskas FW
and Collins T: Salicylates inhibit I kappa B-alpha phosphorylation,
endothelial-leukocyte adhesion molecule expression, and neutrophil
transmigration. J Immunol. 156:3961–3969. 1996.PubMed/NCBI
|
|
50
|
Patil KR, Mohapatra P, Patel HM, Goyal SN,
Ojha S, Kundu CN and Patil CR: Pentacyclic Triterpenoids Inhibit
IKKβ mediated activation of NF-κB Pathway: In Silico and in vitro
evidences. PLoS One. 10:e01257092015. View Article : Google Scholar
|
|
51
|
Rotblat B, Grunewald TG, Leprivier G,
Melino G and Knight RA: Anti-oxidative stress response genes:
Bioinformatic analysis of their expression and relevance in
multiple cancers. Oncotarget. 4:2577–2590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chora AA, Fontoura P, Cunha A, Pais TF,
Cardoso S, Ho PP, Lee LY, Sobel RA, Steinman L and Soares MP: Heme
oxygenase-1 and carbon monoxide suppress autoimmune
neuroinflammation. J Clin Invest. 117:438–447. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gozzelino R, Jeney V and Soares MP:
Mechanisms of cell protection by heme oxygenase-1. Annu Rev
Pharmacol Toxicol. 50:323–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kim YR, Oh JE, Kim MS, Kang MR, Park SW,
Han JY, Eom HS, Yoo NJ and Lee SH: Oncogenic NRF2 mutations in
squamous cell carcinomas of oesophagus and skin. J Pathol.
220:446–451. 2010. View Article : Google Scholar
|
|
55
|
Qi Z, Ci X, Huang J, Liu Q, Yu Q, Zhou J
and Deng X: Asiatic acid enhances Nrf2 signaling to protect HepG2
cells from oxidative damage through Akt and ERK activation. Biomed
Pharmacother. 88:252–259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ding Y, Chen M, Wang M, Wang M, Zhang T,
Park J, Zhu Y, Guo C, Jia Y, Li Y and Wen A: Neuroprotection by
acetyl-11-Keto-β-Boswellic acid, in ischemic brain injury involves
the Nrf2/HO-1 defense pathway. Sci Rep. 4:70022014. View Article : Google Scholar
|
|
57
|
Yan SL, Yang HT, Lee YJ, Lin CC, Chang MH
and Yin MC: Asiatic acid ameliorates hepatic lipid accumulation and
insulin resistance in mice consuming a high fat diet. J Agric Food
Chem. 62:4625–4631. 2014. View Article : Google Scholar : PubMed/NCBI
|
